health 💉 CEPI backs Egyptian Ebola vaccine push
The Coalition for Epidemic Preparedness Innovations (CEPI) has pledged up to $16.5 million to advance Minapharm's Bundibugyo vaccine candidate into human trials. This support targets the ongoing Bundibugyo ebolavirus outbreak, which has seen over 2,700 deaths mainly in the Democratic Republic of Congo. The funding will allow the Egyptian drugmaker to move the vaccine through preclinical tests and into an early-stage safety study in Africa. This candidate is notable because it aims to induce both B- and T-cell responses for lasting immunity. This initiative also helps secure Phase 1 trial capacity within Africa for various vaccine developers.